Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT
T Murakami1, T Kim, M Takamura
1Department of Radiology, Osaka University Medical School, 2-2 Yamadaoka, Suita-city, Osaka, 565-0871, Japan. murakami@radiol.med.osaka-u.ac.jp
Radiology
|March 7, 2001
Summary
Double arterial phase imaging significantly improves the detection of hypervascular hepatocellular carcinoma (HCC). This technique enhances sensitivity and reduces false positives compared to single arterial phase imaging.
Area of Science:
- Radiology
- Hepatobiliary Imaging
- Oncologic Imaging
Background:
- Hepatocellular carcinoma (HCC) is a common primary liver malignancy.
- Early and accurate detection of hypervascular HCC is crucial for effective patient management.
- Current imaging techniques may have limitations in fully characterizing hypervascular HCC lesions.
Purpose of the Study:
- To evaluate the efficacy of double arterial phase imaging using multi-detector row helical computed tomography (MDCT) for detecting hypervascular HCC.
- To compare the diagnostic performance of double arterial phase imaging against single arterial phase imaging (early and late) for HCC detection.
Main Methods:
- Fifty-one patients with known hypervascular HCC underwent dual arterial phase MDCT of the liver.
- Early and late arterial phase images were acquired sequentially with a 5.0-second interscan delay.
- Image analysis by three independent observers assessed sensitivity, positive predictive value, and AUC for HCC detection.
Main Results:
- Double arterial phase imaging achieved a sensitivity of 86% and a positive predictive value of 92% for hypervascular HCC.
- This dual-phase approach demonstrated significantly higher sensitivity (P < .05) and AUC compared to early or late phases alone.
- Double arterial phase imaging resulted in the fewest false-positive lesions.
Conclusions:
- Double arterial phase imaging is a recommended technique to enhance the detection of hypervascular HCC.
- This imaging strategy effectively improves diagnostic accuracy and reduces false-positive findings in HCC diagnosis.


